CRISPR Therapeutics

Gene-editing biotech wielding bacterial immune systems as precision scalpels—CRISPR-Cas9 cutting DNA like restriction enzymes. Therapies mimic horizontal gene transfer: inserting corrected sequences to fix sickle cell, beta-thalassemia mutations.